With a budgetary increase of $297 million in FY2020, NCI anticipates funding more than 125 additional competing awards over FY19 levels—and devoting more than $210 million in new funding to support extramural research and training opportunities.
Consider these data points on cancer disparities:
Having cancer as a Latino in the United States has important implications potentially related to risk of carcinogenesis, knowledge of cancer prevention, access to cancer screening, therapy timing and choices, and access to good supportive/palliative or survivorship care.
The NCI Board of Scientific Advisors has approved seven new and reissue concepts—Requests for Applications, Requests for Proposals, and PARs.
We went through our analytics: here is what your colleagues in oncology read in 2019.
The Annals of Internal Medicine has published a correction to the controversial meta-analyses of health outcomes related to consumption of red and processed meat—announcing that the lead author of the journal's “new guidelines,” Bradley Johnston, didn't disclose funding from AgriLife Research.
As I look through just-published tables of age-adjusted cancer mortality, I recognize an unprecedented development:
The ink hadn't dried on the headline of the lead story in the Dec. 29 issue of The New York Times when on Jan. 2 HHS Secretary Alex Azar and newly arrived FDA Commissioner Stephen M. Hahn made the following announcement:
FDA Jan. 2 issued a final guidance that will restrict the sale of e-cigarette flavors most popular with minors.
Thomas Jefferson University and Temple University Dec. 18 entered into a binding definitive agreement for Jefferson's acquisition of Fox Chase Cancer Center and Temple's Bone Marrow Transplant Program.
